1APPLEBY SB, RISTIMAKI A, NEILSON K, et al. Structure of the human cyclooxygenase - 2 gene [J]. Biochem J, 1994, 302 ( part3 ) : 723-727.
2HLA T,NEILSON K. Human Cyclooxygenase-2 cDNA [J]. Proc Natl Acad Sci USA, 1992,89 (16) : 7384-7388.
3CHANG SH, LIU CH, CONWAY R, et al. Role of prostaglandin E2 dependent angiogeslic switch in eyelooxygenase-2-induced breast cancer progression[J ]. Proc Natl Acad Sci USA, 2004,101 (2) :591-596.
4POCKAJ BA, BASU GD, PATHANGEY LB, et al. Reduced T-cell dendritic cell function is related to cyclooxygenase-2 overpression and prostaglandin E2 secretion in patients with breast cancer[J ]. Ann Surg Oncol,2004,11(3) :328-339.
5KUNDU N, SMYTH MJ, SAMSEL L, et al. Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle [J ]. Breast Cancer Res Treat, 2002,76( 1 ) : 57-64.
6SOROKIN A. Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype [J]. Curr Pharm Des, 2004,10 (6) : 647-657.
7RISTIMAKI A, SIVULA A, LUNDIN J, et al. Prognostic significance of elevated cyclooxygenase - 2 expression in breast cancer [ J ]. Cancer Res, 2002,62 (3) : 632-635.
8SPIZZO G, GASTI G, WOLF D, et al. Correlation of COX-2 and EpCAM overexpression in human invasive breast cancer and its impact on survival[J]. Br J Cancer,2003,88(4) :574-578.
9DENKERT C, WINZER KJ, MULLER BM, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma[ J ]. Cancer, 2003,97 ( 12 ) : 2978-2987.
10WuLFING P,DIALLO R,et al. Analysis of cyclooxygenase-2 expression in human breast cancer:high throughput tissue microarray analysis[ J ]. J Cancer Res Clin Oncol, 2003,129(7) : 375-382.
二级参考文献10
1Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer, 2000, 89:2637-2645.
2Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998, 58:362-366.
3Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 1998, 93: 705-716.
4Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res, 1992,52:5575-5589.
5Eling TE, Thompson DC, Foureman GL, et al. Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol, 1990,30: 1-45.
6Gustafson-Svard C, Lilja I, Hallbook O, et al. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumors in rats. Gut, 1996, 38:79-84.
7Subbaramaiah K, Telang N, Ramonetti JT, et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res, 1996, 56: 4424-4429.
8Brueggemeier RW, Quinn AL, Parrett ML,et al. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett, 1999, 140:27-35.
9Liu XH, Rose DP. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res, 1996, 56:5125-5127.
10Kargman SL, O′Neill GP, Vickers PJ, et al. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res, 1995, 55: 2556-2559.
7Lanza-Jacoby S,Bard R,Rosato FE Jr,et al. Effect of simultane- ous inhibition of epidermal growth factor receptor and cyclooxyge- nase-2 in HER-2/neu--positive breast cancer Clin Cancer Res, 2006.15(12) :6161-6169.
8Thompson AM,Ehon RA,Hawkins RA,et al. PS2 mRNA expres-sion adds prognostic information to node status for 6-year sur- vival in breast cancer.Br J Cancer, 1998,77(3):492.
9Bccnkcn SW, Grizzlc WE. Growc DR,et al. Molccular biomarkers for breast cancer prognosis :eocxpression of C-crbBand P53 [J]. An n Surg,2001,233(5) :630-638.
